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Investigating the genetic underpinnings of early-life irritability
L Riglin1,6, O Eyre1,6, M Cooper1, S Collishaw1, J Martin1,2, K Langley1,3, E Leibenluft4, A Stringaris4, AK Thapar1, B Maughan5,
MC O’Donovan1 and A Thapar1
Severe irritability is one of the commonest reasons prompting referral to mental health services. It is frequently seen in
neurodevelopmental disorders that manifest early in development, especially attention-deﬁcit/hyperactivity disorder (ADHD).
However, irritability can also be conceptualized as a mood problem because of its links with anxiety/depressive disorders; notably
DSM-5 currently classiﬁes severe, childhood-onset irritability as a mood disorder. Investigations into the genetic nature of irritability
are lacking although twin studies suggest it shares genetic risks with both ADHD and depression. We investigated the genetic
underpinnings of irritability using a molecular genetic approach, testing the hypothesis that early irritability (in childhood/
adolescence) is associated with genetic risk for ADHD, as indexed by polygenic risk scores (PRS). As a secondary aim we
investigated associations between irritability and PRS for major depressive disorder (MDD). Three UK samples were utilized: two
longitudinal population-based cohorts with irritability data from childhood (7 years) to adolescence (15–16 years), and one ADHD
patient sample (6–18 years). Irritability was deﬁned using parent reports. PRS were derived from large genome-wide association
meta-analyses. We observed associations between ADHD PRS and early irritability in our clinical ADHD sample and one of the
population samples. This suggests that early irritability traits share genetic risk with ADHD in the general population and are a
marker of higher genetic loading in individuals with an ADHD diagnosis. Associations with MDD PRS were not observed. This
suggests that early-onset irritability could be conceptualized as a neurodevelopmental difﬁculty, behaving more like disorders such
as ADHD than mood disorders.
Translational Psychiatry (2017) 7, e1241; doi:10.1038/tp.2017.212; published online 26 September 2017
INTRODUCTION
Severe irritability has long been recognized as a common
accompanying difﬁculty to neurodevelopmental disorders that
manifest early in development. Irritability is commonly deﬁned as
a heightened propensity to react with anger, grouchiness, or
tantrums relative to peers and is particularly common in
attention-deﬁcit/hyperactivity disorder (ADHD).1–4 Recent esti-
mates suggest it is present in around 25–45% of children with
ADHD, when deﬁned broadly as emotion dysregulation (which
can include an inability to control other emotions, such as
sadness).1 As well as being common, emerging evidence suggests
that irritability—as well as broader constructs which include
irritability (for example, emotion dysregulation, behavioral pro-
blems)—appears to index clinical severity and is associated with
adverse outcomes in individuals with ADHD.4,5 It is currently
unclear how irritability should be conceptualized, particularly
because it is a trans-diagnostic construct. Within DSM-5, irritability
is included as a feature of a number of different diagnostic
categories. Severe chronic childhood irritability has recently been
categorized by the new DSM-5 diagnosis of disruptive mood
dysregulation disorder (DMDD) and classed as a mood disorder
because of links with later depression.6 However, childhood
irritability behaves similarly to ADHD (and other neurodevelop-
mental disorders) in that onset is early in development and levels
tend to decline from childhood to adolescence,7,8 raising the
possibility that earlier-onset irritability behaves more like a
neurodevelopmental difﬁculty such as ADHD, rather than a mood
disorder.
Irritability is one of the most common reasons prompting
referral to mental health services.9 Yet, despite the clinical
importance of irritability, there is a limited understanding of its
genetic architecture. Twin studies suggest that irritability has a
heritability estimate of 30–40%.10 To date, one twin study has
reported signiﬁcant genetic overlap between emotional dysregu-
lation (a construct closely related to irritability) and ADHD
symptoms,11 and family studies also suggest that emotional
lability is elevated in family members of individuals with
ADHD.12,13 However other twin study ﬁndings suggest that
irritability shares genetic liability with depression.14 Molecular
genetic investigations could help clarify the genetic under-
pinnings of irritability but currently investigations at a molecular
level are lacking.
Large genome-wide association studies of patients and controls
can be used (as discovery samples) to derive individual composite
genetic risk scores (PRS—polygenic risk scores) that serve as an
index of genetic liability for the disorder in an independent
(target) sample.15 Given that irritability is so strongly associated
with ADHD, our primary aim was to test the hypothesis that early
irritability would be associated with ADHD PRS. We set out to test
this hypothesis in two longitudinal population-based cohorts with
irritability measured in childhood and adolescence, and in a clinic-
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based sample of young people with ADHD. As a secondary aim,
given the new classiﬁcation of chronic childhood irritability as a
mood disorder in DSM-5, we also investigated associations
between irritability and PRS for major depressive disorder (MDD).
MATERIALS AND METHODS
Samples
Three UK samples were included in the study: two population based
cohorts (the Avon Longitudinal Study of Parents and Children, ALSPAC,16,17
and the National Child Development Study, NCDS)18 and one clinical
sample (the Study of ADHD, Genes and Environment, SAGE)).19
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a well-
established prospective, longitudinal birth cohort study. The enrolled core
sample consisted of 14 541 mothers living in Avon, England, who had
expected delivery dates of between April 1, 1991 and December 31, 1992.
Of these pregnancies 13 988 children were alive at 1 year. Where families
included twins, we included the oldest sibling. When the oldest children
were ~ 7 years of age, the initial sample was augmented with eligible cases
who had failed to join the study originally, resulting in an additional 713
children being enrolled. There was a total of 14 701 children alive at 1 year
of age. In total 9912 ALSPAC children were genotyped, of whom 8365
passed quality control. Full details of the study, measures and sample can
be found elsewhere.16,17 The study website contains details of all the data
that is available through a fully searchable data dictionary (http://www.bris.
ac.uk/alspac/researchers/data-access/data-dictionary). Ethical approval for
the study was obtained from the ALSPAC Ethics and Law Committee and
the Local Research Ethics Committees.
The National Child Development Study (NCDS) is another well-
established prospective, UK birth cohort. The study recruited 18 558
children from England, Wales and Scotland born during one week in 1958.
Genotype data collected at age 44 years were available for 5257
individuals following quality control. Full details of the study are described
elsewhere.18 Ethical approval for the biomedical survey from which genetic
data were available was obtained from the South East Multicentre
Research Ethics Committee.
The Study of ADHD, Genes and Environment (SAGE) is a clinical sample
of children with ADHD recruited from UK child psychiatry and pediatric
clinics between 2007 and 2011. The sample consisted of 696 participants
(84% male) aged 6–18 years (mean= 10.9, s.d. = 2.99) with a clinical
diagnosis of ADHD that was conﬁrmed by research diagnostic interviews.
Genotype data were available for 569 individuals following quality control.
Full details of the study are described elsewhere.19 Ethical approval for
the study was obtained from the Wales Multicentre Research Ethics
Committee.
Polygenic risk scores
PRS were generated as the weighted mean number of disorder risk alleles
in approximate linkage equilibrium using standard procedures.20 ADHD
and MDD risk alleles were identiﬁed from Psychiatric Genomics
Consortium (PGC) analysis of case-control GWAS. For testing ADHD PRS
in ALSPAC, 9 ADHD studies were included in the ADHD discovery data set
(5621 cases and 13 589 controls).21–23 As the ADHD discovery GWAS
included data from NCDS (controls) and SAGE (cases), meta-analyses (using
the standard error scheme in METAL) excluding these samples were
performed to identify risk alleles for the purpose of generating PRS in
NCDS and SAGE (4817 cases and 6510 controls for NCDS; 4980 cases and
11 837 controls for SAGE). For all three samples, eight studies were
included in the MDD discovery data set (9240 cases and 9519 controls).24
Primary analyses deﬁned risk alleles as those associated at p-thresh-
oldo0.5 (previously reported to maximally capture phenotypic variance
for ADHD and MDD); associations across a range of p-thresholds are shown
in Supplementary Figure 1. Further details of the methods for generating
the PRS have been described elsewhere25 and are given in Supplementary
Material. Genotyping details are given in Supplementary Material.
Irritability
Irritability was deﬁned using available parent-reported measures in all
three samples. Details of the speciﬁc items, response scale and
requirements for a participant to be classed as irritable in each sample
are described in the text below and summarized in Table 1. The irritability
items were selected on the basis of previous research26–28 and counted asT
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present if they occurred frequently in the young person (see Table 1 for
details). We generated irritability constructs that were similar but not
identical across each sample given that different measures were available
in each data set.
In ALSPAC, irritability was assessed at three time-points using the
Development and Well-Being Assessment (DAWBA)29 (a structured
research diagnostic interview) at ages 7 years 7 months, 10 years 8 months
and 15 years 6 months. Individuals were categorized as irritable if they
were rated as having at least one of three symptoms (severe temper
tantrums, touchy and easily annoyed, angry and resentful) ‘a lot more than
others’.
In NCDS, irritability data were available from a single item from the
abbreviated Rutter A scale30 at three time points—ages 7, 11 and 16 years.
Individuals were categorized as irritable if they were rated as being
‘frequently irritable, quick to ﬂy off the handle’.
In the clinical sample of participants with ADHD (SAGE), irritability was
assessed at one time point (age range 6–18 years) using the Child and
Adolescent Psychiatric Assessment (CAPA)31 (a semi-structured research
diagnostic interview). Individuals were categorized as irritable if they were
rated as having at least one of three symptoms (temper tantrums, touchy
or easily annoyed or angry and resentful). These had to occur frequently
over the past three months (at least four times per week for touchy/easily
annoyed or angry/resentful, or three times per week for temper tantrums),
uncontrollably, and interfere with at least two activities. For sensitivity
analyses a continuous score (possible range 0–3) was also generated.
ADHD symptoms
ADHD symptoms were measured using the parent-reported DAWBA in
ALSPAC (corresponding to the 18 DSM-IV symptoms, possible range 0–36),
the Rutter A scale in NCDS (two items: ‘is squirmy or ﬁdgety’ and ‘has
difﬁculty in settling to anything for more than a few moments’/‛very
restless, has difﬁculty staying seated for long’, possible range 0–4) and the
CAPA in SAGE (18 DSM symptoms, possible range 0–18).
Analyses
We ﬁrst examined irritability in each of the samples: speciﬁcally, how
common it was, the prevalence at different ages, and associations with sex
and total ADHD symptom scores.
The primary analyses tested for associations between ADHD PRS and
irritability using logistic regressions in SPSS. Sex and 10 population
stratiﬁcation principal components were included as covariates in all PRS
analyses. Proportion of variance explained was calculated as the difference
between the Nagelkerke pseudo-R-square in the model including PRS
compared with the null model that did not include PRS (ΔR2).
Developmental differences were assessed in the longitudinal population
samples, by comparing genetic risk associations with irritability in
childhood and adolescence. In the clinical ADHD sample, measures were
available at only one time point; thus, sensitivity analyses were run
splitting the sample into two age groups (o12 years (N=408) and ⩾ 12
years (N=288)). In all three samples, effects of age were investigated by
testing for a PRS-by-age interaction (a random effects model was included
for the population samples where irritability was assessed at multiple time
points).
RESULTS
Table 2 shows descriptive information about irritability in each of
the samples.
In ALSPAC, around 4% of the sample met the criteria for
irritability at each of the three time points (ages 7, 10 and 15
years). More boys than girls met the criteria in childhood (ages 7
and 10) but not in adolescence (age 15)—there was a sex-by-age
interaction (z =− 4.72, Po0.001) whereby irritability decreased
from ages 7 to 15 in boys and increased in girls (z =− 1.76,
P= 0.078 and z = 4.68, Po0.001 respectively).
In NCDS, between 9 and 13% of the sample met the criteria for
irritability at each of the three time points (age 7, 11 and 16).
Again, more boys met the criteria in childhood (age 11), while
more girls met the criteria in adolescence (age 16), with a sex-by-
age interaction (z=− 5.31, Po0.001) whereby irritability
decreased from age 7 to 16 in boys and increased in girls
(z=− 5.26, Po0.001 and z= 2.12, P= 0.034 respectively).
Thus, despite different prevalence rates (and measures) of
irritability in the two population samples, both showed similar
developmental trends and sex differences.
Table 2. Irritability descriptive statistics and associations with ADHD symptom levels and sex
(a) Population sample: ALSPAC Age 7 Age 10 Age 15
Sample N 7963 7558 4602
Frequency 3.9% 4.0% 4.2%
Frequency in males 5.2% 5.1% 3.8%
Frequency in females 2.5% 2.9% 4.5%
Sex difference (χ2(1)) 40.20, Po0.001 23.72, Po0.001 1.26, P= 0.262
ADHD symptoms (OR) 1.17 (1.16–1.19) Po0.001 1.18 (1.17–1.20) Po0.001 1.18 (1.16–1.20) Po0.001
(b) Population sample: NCDS Age 7 Age 11 Age 16
Sample N 8201 8011 7063
Frequency 10.4% 13.1% 9.4%
Frequency in males 10.9% 14.1% 7.7%
Frequency in females 9.9% 12.0% 11.1%
Sex difference (χ2(1)) 1.97, P= 0.160 7.78, P= 0.005 24.47, Po0.001
ADHD symptoms (OR) 1.90 (1.80–2.02) Po0.001 1.79 (1.70–1.89) Po0.001 1.78 (1.67–1.90) Po0.001
(c) ADHD sample: SAGE (Age 6–18)
Sample N 678
Frequency 90.9%
Frequency in males 89.0%
Frequency in females 91.2%
Sex difference (χ2(1)) 0.54, P= 0.461
ADHD symptoms (OR) 1.25 (1.16–1.35) Po0.001
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; ALSPAC, The Avon Longitudinal Study of Parents and Children; NCDS, The National Child
Development Study; SAGE, The Study of ADHD, Genes and Environment. N= sample with irritability data.
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In SAGE, the patient sample, 91% of the sample met criteria for
irritability, with no sex difference in prevalence although irritability
was more common in the ‘younger’ (⩽11 years) than ‘older’ (⩾12
years) subsamples (93.5% and 87.0% respectively, χ2(1) = 8.36,
P= 0.004).
Irritability was consistently associated with ADHD total symp-
tom scores at all ages in all samples (Table 2).
Association between irritability and ADHD PRS
Associations between ADHD PRS and irritability are given in
Table 3. Within the population-based samples, ADHD PRS were
associated with irritability in ALSPAC at all ages. In NCDS, ADHD
PRS were not associated with irritability (Po0.1 at age 7 only).
Within the ADHD clinical sample (SAGE), ADHD PRS were
associated with irritability. Because of the high prevalence of
irritability in the clinical sample, a continuous measure of
irritability was also examined. The pattern of association was
similar, but non-signiﬁcant (β= 0.077, P= 0.073, see Supplemen-
tary Table 1).
Sensitivity analyses in the clinical ADHD sample indicated no
clear age effects (younger subsample OR= 1.48 (0.92–2.39),
P= 0.110; older subsample OR= 1.53 (0.99–2.36), P= 0.053) and
there was no evidence of any interaction between ADHD PRS
score and either age or sex at Po0.05 in any of the samples.
Association between irritability and MDD PRS
Associations between MDD PRS and irritability are shown in
Table 4. MDD PRS were not associated with irritability in either of
the population samples at any age, or in the ADHD clinical sample
(SAGE, including when using a continuous score, see Supplemen-
tary Table 1). Sensitivity analyses in the clinical ADHD sample
indicated no clear age effects (younger subsample OR= 0.84
(0.54–1.32), P= 0.448; older subsample OR= 1.19 (0.77–1.81),
P= 0.435). The only evidence of an interaction between MDD
PRS score and age across samples was a stronger association at
age 7 than age 10 in ALSPAC (z=− 2.04, P= 0.041); there was no
evidence for an interaction between MDD PRS and sex at Po0.05
in any of the samples.
DISCUSSION
This study aimed to investigate the genetic underpinnings of early
irritability, by testing the hypothesis that it would be associated
with ADHD genetic liability, as indexed by polygenic risk scores for
clinical ADHD. We observed associations between ADHD PRS and
early irritability in a population-based cohort and in an ADHD
clinical sample. These ﬁndings are in keeping with those from a
previous twin study and suggest modest genetic overlap between
ADHD and irritability at a molecular (common variant) level.21–23
The results from the patient ADHD sample further suggest that
irritability is a clinical marker of genetic loading in this group.
There are several reasons why ADHD PRS might be associated
with irritability. One possibility is that it is a core feature of ADHD:
irritability was historically included as an associated feature of
ADHD and it remains a commonly co-occurring symptom.1,32 It
also appears to show similar epidemiological patterns to ADHD
and many other DSM-5 neurodevelopmental disorders—symptom
levels have been reported to be highest in childhood and to
reduce with age,8 a pattern we observed in males. We also found a
male preponderance for irritability in our population samples, at
least in childhood,33 although sex differences in irritability have
not been consistent in previous work (see below). There is also
some evidence that effective ADHD treatment with stimulant
medication improves irritability in children with ADHD.34 However,
symptoms of irritability are not prominent in all children with
ADHD1 (although they are very common in our clinical sample),
suggesting that irritability might provide additional information
regarding severity of disorder and genetic loading within those
with ADHD. Notably, associations between ADHD PRS and
irritability were similar after taking into account ADHD (and
Conduct Disorder) symptom levels in our clinical sample,
suggesting these are not entirely the same constructs (Supple-
mentary Material).
Another possibility is that ADHD common genetic risk variants
have pleiotropic effects on ADHD and early irritability in the
population. Studies have already shown that ADHD polygenic risk
scores are associated with other features that commonly
accompany ADHD, such as lower IQ, working memory and
conduct disorder,35,36 as well as ADHD trait levels in the general
population.37,38 This is the ﬁrst study that we are aware of that has
shown an association with irritability, thereby addressing a gap in
knowledge of the genetic architecture of early irritability. Twin
studies highlight that psychopathology co-occurs as a result of
shared genetic risks39 and molecular genetic studies concur in
showing that ADHD genetic risk variants impact upon a wide
range of early neurodevelopmental and behavioral traits. It is
possible that ADHD PRS could have non-speciﬁc effects on
multiple psychiatric traits in early life, although ﬁndings do
suggest there could be some speciﬁcity in the pattern of effects.36
Table 3. Associations between ADHD polygenic risk scores and
irritability
OR (95% CI) p ΔR2
(a) Population sample: ALSPAC
Age 7 (N= 5584) 1.20 (1.04–1.38) 0.010 0.005
Age 10 (N= 5432) 1.22 (1.06–1.40) 0.007 0.005
Age 15 (N= 3602) 1.20 (1.02–1.42) 0.031 0.004
(b) Population sample: NCDS
Age 7 (N= 4960) 1.09 (0.99–1.20) 0.085 0.002
Age 11 (N= 4544) 1.06 (0.97–1.15) 0.220 0.001
Age 16 (N= 4023) 1.02 (0.91–1.13) 0.779 0.0001
(c) ADHD sample: SAGE
Age 6–18 (N= 560) 1.37 (1.02–1.86) 0.039 0.017
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; ALSPAC, The
Avon Longitudinal Study of Parents and Children; NCDS, The National
Child Development Study; SAGE, The Study of ADHD, Genes and
Environment. ADHD polygenic risk score using p-threshold o0.5. Analyses
controlling for sex and 10 principle components.
Table 4. Associations between MDD polygenic risk scores and
irritability
OR (95% CI) P ΔR2
(a) Population sample: ALSPAC
Age 7 (N= 5584) 1.09 (0.95–1.25) 0.239 0.001
Age 10 (N= 5432) 0.91 (0.79–1.05) 0.184 0.001
Age 15 (N= 3602) 1.02 (0.87–1.21) 0.785 0.0001
(b) Population sample: NCDS
Age 7 (N= 4690) 1.01 (0.92–1.12) 0.793 0.0001
Age 11 (N= 4544) 1.07 (0.98–1.17) 0.153 0.001
Age 16 (N= 4023) 0.97 (0.86–1.08) 0.536 0.0002
(c) ADHD sample: SAGE
Age 6–18 (N= 560) 1.05 (0.78–1.41) 0.763 0.0004
Abbreviations: ALSPAC, The Avon Longitudinal Study of Parents and
Children; MDD, major depressive disorder; NCDS, The National Child
Development Study; SAGE, The Study of ADHD, Genes and Environment.
MDD polygenic risk score using p-threshold o0.5. Analyses controlling for
sex and 10 principle components.
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Although our study suggests that early irritability is associated
with ADHD genetic risk scores, it is also important to note that
previous longitudinal studies have found associations between
early irritability and later emotional/mood disorders in general
population samples:10,14 links which appear to be partially
genetically mediated.14,40 Such ﬁndings have suggested that
childhood irritability is an early manifestation of mood problems.
Indeed severe childhood-onset irritability (DMDD) is classiﬁed as a
mood disorder in the DSM-5. The DSM-5 classiﬁcation of
childhood-onset irritability as a mood disorder would predict an
association between early irritability and MDD PRS, which we did
not ﬁnd. However, interestingly, in both of our population-based
cohorts we found developmental differences in the pattern of
prevalence rates of irritability for males and females; the
prevalence decreased from childhood to adolescence in males
(a pattern typical of neurodevelopmental disorders) but increased
for females (a pattern typical of mood disorders). Although
previous studies have not consistently found sex differences in
irritability,8,41–45 the age range and type of sample (e.g. clinical vs
population) in which irritability has been measured has varied
across studies, which may in part explain the differing ﬁndings. We
suggest that the manifestation of irritability might represent
different underlying problems depending on age and sex; that is,
it could be more like ADHD in childhood and more like mood
disorder later in development. The ﬁndings from this study
suggest that future studies need to adopt a developmental
approach in deﬁning and investigating irritability, for example by
considering age of onset, even though this is not an explicit
requirement in R-DoC.46,47
Secondary analyses found no association between irritability
and PRS for MDD in our samples (see Supplementary Table 2).
However, these ﬁndings should be interpreted cautiously. Despite
similar GWAS discovery sample sizes (N= 18 759 for MDD; N= 19
210 for ADHD), MDD PRS will be underpowered compared with
ADHD PRS for several reasons, including that MDD is more
common and less heritable than ADHD.48 Another difference
worth noting is that while the ADHD PRS were generated based
on a GWAS on children with ADHD, the MDD PRS were generated
based on a GWAS of adult MDD. Indeed, there is emerging
evidence that the genetic architecture of MDD may differ by age-
at-onset48 and MDD PRS derived from a GWAS of younger patients
with MDD may have resulted in stronger associations with
childhood irritability. Nevertheless, if childhood irritability is an
early manifestation of later, adult, mood problems, an association
between childhood irritability and adult-MDD PRS would be
predicted. Thus, while we can likely exclude large effect sizes of
MDD PRS on early irritability, we cannot rule out an association
with genetic liability for depression, especially given ﬁndings
from twin studies.14,40 Large scale international molecular genetic
studies show genetic overlap between ADHD and depression,49–51
and these disorders co-occur more often than would be expected
by chance;52 as a result, it is possible that irritability is a common
factor between the two.
Another explanation is that early irritability is neurodevelop-
mental in nature (that is, manifest early and more common in
males), but its links with later depression are mediated via gene-
environment correlation (for example via eliciting adverse social
stressors such as peer rejection). Such mechanisms would be
incorporated into estimates of shared genetic effects in twin
studies. Research into whether irritability mediates the association
between ADHD and later depression is ongoing.4,53 We encourage
future work investigating irritability across different developmen-
tal stages, across sex and within different disorders to help identify
similarities, as well as differences in presentation, associated
characteristics and treatment response. The ﬁndings from this
study suggest that while irritability is a trans-diagnostic construct,
future studies need to adopt a developmental approach in
deﬁning and investigating it.
Although there are a number of strengths to this study—in
particular the use of three independent samples—there are also a
number of limitations that should be noted. First, measurement of
irritability varied across the three samples. In ALSPAC and SAGE
we used three items, which have previously been used to measure
irritability (informed by factor analyses),3,28,54,55 although in
ALSPAC parents were asked about irritability compared with
others, while in SAGE parents were asked about the presence/
absence of irritability. In NCDS we were limited to one irritable
item, which asked about the frequency of irritability, and was
more frequently endorsed than in ALSPAC (for example, 10.4%
compared with 3.9%, at age 7) and thus likely represents a less
severe presentation of irritability. Measurement differences may
have inﬂuenced observed associations. Despite different measures
we did observe associations between ADHD PRS and irritability in
both the ADHD clinical sample and the other population sample
(ALSPAC). In fact, these consistent ﬁndings across samples and
varying instruments and deﬁnitions of irritability increase con-
ﬁdence about their robustness. It is also worth noting that the
level of irritability we are measuring in all three samples (at least
one frequent irritable symptom), is not equivalent to the chronic
severe irritability that characterizes the new diagnosis of DMDD,
which has been researched by others.
Second, ALSPAC and NCDS are longitudinal birth cohort studies
that show non-random attrition. Speciﬁcally, individuals with
lower ADHD PRS and lower levels of irritability are more likely to
have remained in the studies.56,57 This may have been particularly
problematic in NCDS where DNA was collected at age 44 years (for
example, ADHD, especially in those also with behavioral problems
including irritability, is associated with premature death).5 Such
bias may have resulted in an underestimation of the association
between ADHD PRS and irritability, particularly in adolescence
when there was more attrition.
Finally, the PRS were based on an available discovery GWAS and
only explain a small proportion of phenotypic variance due to
current discovery sample sizes,58 (with SNP heritability estimated
to be roughly 0.2–0.3 for ADHD and MDD20). Nevertheless, they
are useful biological indicators of disease risk,20 that can aid the
investigation of the genetic architecture of phenotypes in
different samples. Our effect sizes are in line with other work
using similar approaches.36,59
In conclusion, this study suggests that irritability, when manifest
during childhood and adolescence in the general population and
in patients with ADHD, is associated with ADHD genetic liability as
indexed by PRS. This ﬁnding, coupled with observations that
irritability tends to decline from childhood to adolescence,
suggests early irritability is similar to ADHD and, when early in
onset, may be better conceptualized as a neurodevelopmental
difﬁculty rather than a mood disorder-related problem. Further
work is needed to better understand the developmental nature of
irritability and its links with psychiatric disorders.14
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